Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$77.05
0.540.71%
À la fermeture: -
$77.07
0.020.02%
Après les heures de négociation: 7:58 PM EDT
Comments
Loading...
Évaluations des analystes, objectifs de prix, prévision
Colgate-Palmolive Co a un objectif de cours consensus de $96.4, basé sur les évaluations des 21 analystes. Le plus élevé est de $109 attribué par Deutsche Bank le septembre 9, 2024, et le plus bas est de $80 attribué par Wells Fargo le septembre 25, 2025. Les 3 dernières évaluations d'analystes ont été publiées par Raymond James, JP Morgan et B of A Securities le octobre 20, 2025, octobre 10, 2025 et octobre 8, 2025. Avec un objectif de cours moyen de $90.33 entre Raymond James, JP Morgan et B of A Securities, il y a une variation implicite de 17.21% upside pour Colgate-Palmolive Co à partir de ces dernières évaluations d'analystes.
Sociétés d'analyse émettant des recommandations1
Raymond James
JP Morgan
B of A Securities
UBS
Piper Sandler
1calculé à partir des notes des analystes
Notes d'analystes pour Colgate-Palmolive
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/20/2025 | 23.27% | Raymond James | $105 → $95 | Maintains | Outperform | |||
10/10/2025 | 14.19% | JP Morgan | $95 → $88 | Maintains | Overweight | |||
10/08/2025 | 14.19% | B of A Securities | $98 → $88 | Maintains | Buy | |||
10/08/2025 | 19.38% | UBS | $99 → $92 | Maintains | Buy | |||
10/03/2025 | 9% | Piper Sandler | → $84 | Assumes | → Neutral | |||
10/02/2025 | 18.08% | Goldman Sachs | $106 → $91 | Maintains | Buy | |||
10/01/2025 | 6.4% | Barclays | $87 → $82 | Maintains | Equal-Weight | |||
09/25/2025 | 3.81% | Wells Fargo | $83 → $80 | Maintains | Underweight | |||
08/04/2025 | 36.24% | Citigroup | $108 → $105 | Maintains | Buy | |||
08/04/2025 | 23.27% | JP Morgan | $99 → $95 | Maintains | Overweight | |||
08/04/2025 | 24.57% | Morgan Stanley | $104 → $96 | Maintains | Overweight | |||
08/04/2025 | 7.7% | Wells Fargo | $88 → $83 | Maintains | Underweight | |||
07/25/2025 | 28.46% | JP Morgan | $103 → $99 | Maintains | Overweight | |||
07/17/2025 | 37.54% | UBS | $109 → $106 | Maintains | Buy | |||
07/15/2025 | 12.89% | Barclays | $86 → $87 | Maintains | Equal-Weight | |||
04/28/2025 | 40.14% | Citigroup | $103 → $108 | Maintains | Buy | |||
04/28/2025 | 33.65% | JP Morgan | $95 → $103 | Maintains | Overweight | |||
04/17/2025 | 41.43% | UBS | $105 → $109 | Maintains | Buy | |||
04/11/2025 | 11.59% | Barclays | $89 → $86 | Maintains | Equal-Weight | |||
04/11/2025 | 23.27% | JP Morgan | $99 → $95 | Maintains | Overweight | |||
04/02/2025 | 14.19% | Wells Fargo | $83 → $88 | Maintains | Underweight | |||
03/31/2025 | 38.84% | Piper Sandler | $108 → $107 | Maintains | Overweight | |||
03/27/2025 | 15.48% | Barclays | $83 → $89 | Maintains | Equal-Weight | |||
03/14/2025 | 28.46% | JP Morgan | $97 → $99 | Maintains | Overweight | |||
02/03/2025 | 25.86% | JP Morgan | $103 → $97 | Maintains | Overweight | |||
02/03/2025 | 29.76% | UBS | $104 → $100 | Maintains | Buy | |||
02/03/2025 | 20.67% | Stifel | $95 → $93 | Maintains | Hold | |||
02/03/2025 | 27.16% | RBC Capital | $101 → $98 | Maintains | Sector Perform | |||
02/03/2025 | 36.24% | Raymond James | $110 → $105 | Reiterates | Outperform → Outperform | |||
02/03/2025 | 34.95% | Morgan Stanley | $111 → $104 | Maintains | Overweight | |||
01/29/2025 | 31.05% | RBC Capital | $101 → $101 | Reiterates | Sector Perform → Sector Perform | |||
01/17/2025 | 23.27% | Stifel | $101 → $95 | Maintains | Hold | |||
01/17/2025 | 7.7% | Barclays | $96 → $83 | Maintains | Equal-Weight | |||
01/16/2025 | 34.95% | UBS | $112 → $104 | Maintains | Buy | |||
01/16/2025 | 33.65% | JP Morgan | $109 → $103 | Maintains | Overweight | |||
01/08/2025 | 29.76% | TD Cowen | $110 → $100 | Maintains | Buy | |||
01/07/2025 | 7.7% | Wells Fargo | $92 → $83 | Maintains | Underweight | |||
01/06/2025 | 45.33% | Piper Sandler | $121 → $112 | Maintains | Overweight | |||
10/28/2024 | 45.33% | UBS | $122 → $112 | Maintains | Buy | |||
10/28/2024 | 19.38% | Wells Fargo | $100 → $92 | Maintains | Underweight | |||
10/28/2024 | 42.73% | TD Cowen | $115 → $110 | Maintains | Buy | |||
10/28/2024 | 31.05% | Stifel | $105 → $101 | Downgrade | Buy → Hold | |||
10/11/2024 | 47.92% | JP Morgan | $113 → $114 | Maintains | Overweight | |||
09/24/2024 | 57.01% | Piper Sandler | → $121 | Initiates | → Overweight | |||
09/16/2024 | 29.76% | Wells Fargo | → $100 | Downgrade | Equal-Weight → Underweight | |||
09/09/2024 | 41.43% | Deutsche Bank | $107 → $109 | Downgrade | Buy → Hold | |||
09/04/2024 | 58.3% | UBS | $119 → $122 | Maintains | Buy | |||
07/30/2024 | 49.22% | TD Cowen | $110 → $115 | Maintains | Buy | |||
07/30/2024 | 33.65% | Bernstein | $100 → $103 | Maintains | Market Perform | |||
07/29/2024 | 38.84% | Deutsche Bank | $104 → $107 | Maintains | Buy | |||
07/29/2024 | 44.03% | Morgan Stanley | $103 → $111 | Maintains | Overweight | |||
07/29/2024 | 24.57% | Barclays | $91 → $96 | Maintains | Equal-Weight | |||
07/26/2024 | — | HSBC | — | Downgrade | Buy → Hold | |||
07/24/2024 | 23.27% | Jefferies | $103 → $95 | Downgrade | Buy → Hold | |||
07/23/2024 | 42.73% | TD Cowen | → $110 | Initiates | → Buy | |||
07/22/2024 | 36.24% | Stifel | $95 → $105 | Maintains | Buy | |||
07/19/2024 | 18.08% | Barclays | $85 → $91 | Maintains | Equal-Weight | |||
07/18/2024 | 37.54% | Evercore ISI Group | $100 → $106 | Maintains | Outperform | |||
07/17/2024 | 34.95% | Deutsche Bank | $98 → $104 | Maintains | Buy | |||
07/10/2024 | 45.33% | Citigroup | $103 → $112 | Maintains | Buy | |||
07/10/2024 | 42.73% | B of A Securities | $100 → $110 | Maintains | Buy | |||
07/10/2024 | 25.86% | Wells Fargo | $92 → $97 | Maintains | Equal-Weight | |||
06/24/2024 | 41.43% | Exane BNP Paribas | → $109 | Initiates | → Outperform | |||
05/28/2024 | 33.65% | Morgan Stanley | $101 → $103 | Maintains | Overweight | |||
05/15/2024 | 38.84% | Argus Research | $97 → $107 | Maintains | Buy | |||
04/30/2024 | 10.29% | Barclays | $84 → $85 | Maintains | Equal-Weight | |||
04/29/2024 | 19.38% | Wells Fargo | $90 → $92 | Maintains | Equal-Weight | |||
04/29/2024 | 23.27% | Stifel | $94 → $95 | Maintains | Buy | |||
04/29/2024 | 29.76% | B of A Securities | $90 → $100 | Maintains | Buy | |||
04/29/2024 | 23.27% | RBC Capital | $88 → $95 | Maintains | Sector Perform | |||
04/16/2024 | 29.76% | Citigroup | $95 → $100 | Maintains | Buy | |||
04/12/2024 | 9% | Barclays | $82 → $84 | Maintains | Equal-Weight | |||
04/10/2024 | 21.97% | Stifel | $89 → $94 | Maintains | Buy | |||
04/08/2024 | 24.57% | Evercore ISI Group | $90 → $96 | Maintains | Outperform | |||
03/01/2024 | 20.67% | Goldman Sachs | → $93 | Reinstates | → Buy | |||
01/29/2024 | 20.67% | Morgan Stanley | $85 → $93 | Maintains | Overweight | |||
01/29/2024 | 23.27% | UBS | $93 → $95 | Maintains | Buy | |||
01/29/2024 | 14.19% | Wells Fargo | $80 → $88 | Maintains | Equal-Weight | |||
01/29/2024 | 18.08% | Raymond James | → $91 | Upgrade | Market Perform → Outperform | |||
01/18/2024 | 16.78% | JP Morgan | $88 → $90 | Maintains | Overweight | |||
01/16/2024 | 6.4% | Barclays | $75 → $82 | Maintains | Equal-Weight | |||
12/15/2023 | 16.78% | B of A Securities | → $90 | Upgrade | Neutral → Buy | |||
11/29/2023 | 14.19% | JP Morgan | $83 → $88 | Maintains | Overweight | |||
11/13/2023 | 12.89% | Jefferies | → $87 | Initiates | → Buy | |||
10/30/2023 | 3.81% | RBC Capital | $79 → $80 | Maintains | Sector Perform | |||
10/30/2023 | 10.29% | Morgan Stanley | $89 → $85 | Maintains | Overweight | |||
10/17/2023 | -2.68% | B of A Securities | $85 → $75 | Maintains | Neutral | |||
10/16/2023 | 5.1% | Stifel | $85 → $81 | Upgrade | Hold → Buy | |||
10/12/2023 | -5.28% | Barclays | $81 → $73 | Maintains | Equal-Weight | |||
10/12/2023 | 5.1% | JP Morgan | $85 → $81 | Maintains | Overweight | |||
10/11/2023 | 10.29% | Citigroup | $92 → $85 | Maintains | Buy | |||
09/22/2023 | 9% | HSBC | → $84 | Initiates | → Buy | |||
08/01/2023 | 5.1% | Barclays | $77 → $81 | Maintains | Equal-Weight | |||
07/31/2023 | 7.7% | RBC Capital | → $83 | Reiterates | Sector Perform → Sector Perform | |||
07/31/2023 | 18.08% | Deutsche Bank | $88 → $91 | Maintains | Buy | |||
05/01/2023 | 10.29% | B of A Securities | $80 → $85 | Maintains | Neutral | |||
05/01/2023 | 18.08% | Evercore ISI Group | $85 → $91 | Maintains | Outperform | |||
05/01/2023 | 7.7% | RBC Capital | $82 → $83 | Maintains | Sector Perform | |||
05/01/2023 | 24.57% | Goldman Sachs | $86 → $96 | Maintains | Buy | |||
05/01/2023 | 15.48% | Morgan Stanley | $82 → $89 | Maintains | Overweight |
FAQ
Quel est le cours indicatif de l'action Colgate-Palmolive (CL) ?
Le dernier objectif de prix pour Colgate-Palmolive (NYSE:CL) a été rapporté par Raymond James le octobre 20, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $95.00 s'attendant à ce que CL se rise dans les 12 prochains mois (un possible changement de 23.27% upside). 38 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
Quelle est la note d'analyste la plus récente pour Colgate-Palmolive (CL) ?
La dernière note d'analyste pour Colgate-Palmolive (NYSE:CL) a été fournie par Raymond James, et Colgate-Palmolive maintenu leur note outperform.
Quand a eu lieu la dernière mise à niveau pour Colgate-Palmolive (CL) ?
La dernière amélioration pour Colgate-Palmolive Co a eu lieu le janvier 29, 2024 lorsque Raymond James a augmenté leur objectif de prix à $91. Raymond James avait précédemment a market perform pour Colgate-Palmolive Co.
Quand a eu lieu la dernière dégradation pour Colgate-Palmolive (CL) ?
La dernière réduction pour Colgate-Palmolive Co a eu lieu le octobre 28, 2024 lorsque Stifel a changé leur objectif de prix de $105 à $101 pour Colgate-Palmolive Co.
Quand la prochaine note d'analyste sera-t-elle publiée ou mise à jour pour Colgate-Palmolive (CL) ?
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Colgate-Palmolive, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Colgate-Palmolive a été déposée le octobre 20, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 20, 2026.
La note d'analyste pour Colgate-Palmolive (CL) est-elle correcte ?
Bien que les évaluations soient subjectives et changeront, la dernière note de Colgate-Palmolive (CL) était un maintenu avec un objectif de prix de $105.00 à $95.00. Le prix actuel de Colgate-Palmolive (CL) est de $77.07, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.